Regulation 2

In the MediShield Life Scheme Regulations 2015 (G.N. No. S 622/2015) (called in these Regulations the principal Regulations), in regulation 2(1), in the definition of “approved outpatient treatment”, after paragraph (m), insert —“(n)autologous bone marrow transplant for the treatment of multiple myeloma provided on or after 1 June 2026;